Charlotte Allerton, Head of Discovery and Early Development at Pfizer joins Paul Biondi, Flagship Executive Partner and President of Pioneering Medicines, for a discussion about pioneering partnerships that leverage capabilities from across the biopharma industry to develop potentially transformational therapeutics, including the strategic alliance between Pfizer and »Æ¹ÏÊÓƵapp.
More from:
Human Health

Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies

Halting the Trajectory of Disease with Preemptive Health

AI in Action
